21 May 2013
Keywords: biosante, gains, new, fda, spa, libigel, firm
Article | 04 August 2008
US firm BioSante Pharmaceuticals has reached an additional agreement with the US Food and Drug Administration under the Special Protocol
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 August 2008
18 August 2008
20 May 2013
© 2013 thepharmaletter.com